PHARMA 313 LIMITED
Significant control: Abdul Rahim Butt (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
What does Pharma 313 Limited sell?
Registered activity: Other professional, scientific and technical activities n.e.c. (SIC 74909). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
PHARMA 313 LIMITED is an active private limited company (company number 11817385) incorporated on 11 February 2019, registered in Manchester. Its registered activity is other professional, scientific and technical activities n.e.c. (SIC 74909). Latest micro accounts cover the period ending 28 February 2025, showing net assets of £160k, with 5 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 18% on the prior period (£195k).
By net assets it sits in the top quarter of 2,843 comparable companies in Manchester (median £9,760, upper quartile £50k).
Ownership and control
- Mr Abdul Rahim Butt
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr Mohammad Iqbal Sarwar
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 11 February 20197 yrs ago
- Next accounts due
- 28 November 2026in 35 days
- Confirmation statement due
- 25 February 2027in 124 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 74909
- Other professional, scientific and technical activities n.e.c.
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2025 | £160k | — | — | £9,471 | — | — | 5 |
| 29 February 2024 | £195k | — | — | £1,274 | — | — | 4 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £160,130 at 28 February 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 13.47
- Incorporated five or more years agoIncorporated 11 February 2019
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 124 days
- Next accounts duein 35 days
- Accounts period endNet assets £160k · micro accounts
- Accounts period endNet assets £195k · micro accounts
- Incorporated
Similar companies in Manchester
- LANCASHIRE VEHICLE ASSESSORS LIMITEDManchester · inc. Feb 2019
- LET US SURVEY LIMITEDAltrincham · inc. Feb 2019
- MIAH ASSOCIATES LIMITEDOldham · inc. Feb 2019
- NICK SMITH CONSULTANCY LIMITEDCheadle · inc. Feb 2019
- A. HANSON-FRASER LIMITEDAltrincham · inc. Feb 2019
- DBC PIANO SERVICES LTDManchester · inc. Feb 2019
All companies incorporated on 11 February 2019 · in Feb 2019.
Reminders for PHARMA 313 LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.